Blog

The Kings Fund QMR

What does last year’s NHS spend on pharma look like?

What does last year’s NHS spend on pharma look like?

Reporting by The King’s Fund this year, revealed that total NHS spending on medicines in England rose from around £13 billion in 2010/11 to £17.4 billion in 2016/17. It also revealed that the average reported growth of around 5 per cent a year is outstripping growth in the total NHS budget.

What do these numbers look like?

As specialists in managing and enhancing large and difficult to interpret datasets, we used our next-generation toolkit, RX Analyser, to create a clear, visual interpretation of last year’s NHS pharma spend.

Drilling down to details

When looking at how the health service controls spending on medicines, the King’s Fund reports increased controls on spending and promoting value for money.

A key part of the new guidance is that low-value medicines (e.g., herbal treatments and some painkillers) and products that are widely available over the counter (e.g., for minor illnesses such as coughs and colds) shouldn’t be routinely prescribed in primary care.

NHS Medicines Provision

Actionable analytics at your fingertips

Inspiremed provides powerful data analytics to clients in companies across the healthcare sector. We can help you to make analytics simple and can provide specialist help with your prescribing-related questions.

With our data-driven approach that gives robust, pragmatic and accurate real world analysis, you can build your business strategy with confidence, replacing estimates and guess work with proven facts and figures.

Find out more

Are you ready to gain market analytics and valuable insights and make swift responses to market changes with ease?

To learn more and book your demonstration
info@inspire-med.co.uk
01600 891594

 

Export to Excel is straightforward, which facilitates easy manipulation if required, for example, for territory planning.

Sales and Marketing Manager, Leading Healthcare Company, 2016

Key benefits? Adaptability, flexibility for future changes and cloud-based.

General Manager, Global Healthcare Company

One of the simplest dashboards I have used, this product is very flexible. We use it extensively to gain insight into our business, down to a CCG level.

National Sales Manager, Leading Pharmaceutical Company, 2016

Rx Analyser is already having a significant impact on our business, allowing our Territory Managers to focus on established CCG accounts and identify practice level successes and others for further development.

Managing Director, UK Diabetes Healthcare Company

Fantastic customer service, any requests from us to fine tune the functionality or appearance of the product is done in most cases on the same day as the request.

National Sales Manager, UK Pharmaceutical Company

Obviously I wouldn’t recommend Rx Analyser to our direct competitors as I believe the level of insight provided really gives us an edge.

Sales and Marketing Manager, Leading Healthcare Company, 2016

Sign up for added insights